About Lepranal Pharma
Lepranal Pharma is a Healthcare company based in Hyderabad (India) founded in 1990. It manufactures pharmaceutical drug intermediates and APIs, focusing on oncology and technology improvement. It operates on a B2B model. Its Indian entity Lepranal Pharmaceuticals Private Limited reported revenue of ₹36 Lakh. Lepranal Pharma offers products and services including Drug Intermediates, Ketoralac API, and Carvedilol API. Its focus areas include Pharmaceuticals, Drug Manufacturing, API and Intermediates and Research and Development. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Lepranal Pharmaceuticals, established in 1990, operates in the pharmaceutical sector by manufacturing various therapeutic drug intermediates and APIs like ketoralac and carvedilol. The company emphasizes oncology drug intermediates and invests in research and development for technological advancements and new products. Based in Hyderabad, India, it supplies these products to other firms, integrating sophisticated processes to ensure quality and innovation.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lepranalpharma.com
- Legal Name Lepranal Pharmaceuticals Private Limited
- Date of Incorporation 27 Jul, 1983
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹36 Lakh
FY 2025
- Net Profit₹4 Lakh
FY 2025 · 11% margin
- EBITDA₹4 Lakh
FY 2025 · 11% margin
Associated legal entities of Lepranal Pharma
Lepranal Pharma operates through Lepranal Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lepranal Pharmaceuticals Private Limited CIN U24239TG1983PTC004054 | Active | 27 Jul 1983 | Hyderabad, Telangana | ₹0.4 Cr | 2 | View details |
Products & Services of Lepranal Pharma
Lepranal Pharma offers a comprehensive portfolio of products and services, including Drug Intermediates, Ketoralac API, and Carvedilol API.
Manufactures intermediates for therapeutic drugs including oncology applications
Produces API for pain relief and related treatments
Manufactures API for cardiovascular disease management
Board of directors of Lepranal Pharmaceuticals Private Limited (Lepranal Pharma)
Lepranal Pharmaceuticals Private Limited is the primary company behind Lepranal Pharma. The board of Lepranal Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Indrani Narra, appointed in 2003.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Indrani Narra DIN 02252938 | Director | 27 Oct 2003 | 23 yrs | Lepranal Pharmaceuticals Private Limited |
| Krishna Rao Narra DIN 00683343 | Director | 27 Oct 2003 | 23 yrs | Lepranal Pharmaceuticals Private Limited |
Financials of Lepranal Pharma
Figures of Lepranal Pharmaceuticals Private Limited, the primary company behind Lepranal Pharma, for FY 2025. Revenue was ₹36 Lakh. Net profit was ₹4 Lakh (11% margin). EBITDA was ₹4 Lakh (11% margin).
- ₹36 LakhRevenue · FY 2025
- ₹4 LakhNet profit · 11% margin
- ₹4 LakhEBITDA · 11% margin
- ₹3 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Lepranal Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Lepranal Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Lepranal Pharma
Lepranal Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Lepranal Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lepranal Pharma
Lepranal Pharma was founded in 1990.
Lepranal Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Lepranal Pharma, Lepranal Pharmaceuticals Private Limited, reported revenue of ₹36 Lakh for FY 2025.
Lepranal Pharmaceuticals, established in 1990, operates in the pharmaceutical sector by manufacturing various therapeutic drug intermediates and APIs like ketoralac and carvedilol. The company emphasizes oncology drug intermediates and invests in research and development for technological advancements and new products. Based in Hyderabad, India, it supplies these products to other firms, integrating sophisticated processes to ensure quality and innovation.
Lepranal Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Lepranal Pharma offers Drug Intermediates, Ketoralac API, and Carvedilol API.
Lepranal Pharma operates through Lepranal Pharmaceuticals Private Limited.
The legal entities of Lepranal Pharma currently have 2 directors, including Indrani Narra, Krishna Rao Narra.